Immunopathology mediated by RSV-specific CD4 T cells
Immunopathology mediated by RSV-specific CD4 T cells
批准号:
7895292
负责人:
Steven M Varga
金额:
$3.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-11 至 2010-07-31
关键词:
AddressBiological ModelsCD4 Positive T LymphocytesCD8B1 geneCellsChildDataDevelopmentDiseaseElderlyEosinophiliaEpitopesExhibitsExposure toFailureFormalinGTP-Binding ProteinsGoalsHumanImmuneImmunizationInactivated VaccinesInbred BALB C MiceIndividualInfantInfectionInjuryLower Respiratory Tract InfectionLungLung InflammationLung diseasesMediatingMemoryMusPreventionPulmonary EosinophiliaRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory syncytial virusRoleSeveritiesT-LymphocyteT-Lymphocyte EpitopesTestingTh2 CellsTimeVaccinationVaccinesVaccinia virusViralWorkcytokinedesignglycoprotein Ghuman diseaseimmunopathologymemory CD4 T lymphocytemouse modelnovel strategiespreventresponse
中文摘要
描述(由申请方提供):呼吸道合胞病毒(RSV)是婴幼儿病毒性下呼吸道感染的主要原因。此外,RSV在老年人和免疫受损个体中引起严重疾病。针对RSV的免疫接种与自然感染后增强的疾病和肺嗜酸性粒细胞增多症相关,这被认为是由旺盛的记忆性CD 4 Th 2应答引起的。因此,目前没有批准的RSV疫苗,针对预防疫苗相关疾病的详细研究是开发安全有效疫苗的必要第一步。RSV感染的BALB/c小鼠模型忠实地模拟了人类呼吸道疾病,包括广泛的肺部炎症和损伤、肺嗜酸性粒细胞增多症的发展,以及先前用福尔马林灭活(FI)-RSV或表达附着(G)糖蛋白的重组牛痘病毒(vv)免疫的小鼠中的疾病增强。记忆性CD 4 T细胞分泌Th 2细胞因子是这种反应所必需的,因为它们的消耗消除了嗜酸性粒细胞增多症。最近的研究表明,RSV特异性CD 8 T细胞可以通过迄今未知的机制抑制vvG致敏小鼠中Th 2介导的肺嗜酸性粒细胞增多症。通过利用我们追踪RSV G特异性CD 4 T细胞的能力,我们将确定记忆性CD 8 T细胞抑制RSV G诱导的肺嗜酸性粒细胞增多症的机制。重要的是,最近的工作提供了vvG和FI-RSV免疫可能通过独特的机制诱导RSV疫苗增强的疾病的证据。因此,我们还将确定RSV特异性记忆CD 8 T细胞是否可以预防FI-RSV疫苗增强的疾病。本提案的总体目标是确定RSV特异性记忆CD 8 T细胞如何抑制CD 4 T细胞介导的RSV疫苗增强疾病和免疫病理学的机制。我们提出以下具体目的:1)确定记忆性CD 8 T细胞如何抑制RSV特异性记忆性Th 2细胞和RSV疫苗增强的肺嗜酸性粒细胞增多症,以及2)确定记忆性CD 8 T细胞是否可以预防FI-RSV疫苗增强的疾病和肺损伤。RSV疫苗增强疾病的潜在机制仍不清楚。本提案中的研究旨在确定RSV特异性记忆CD 8 T细胞在降低与人类疾病直接相关的模型系统中CD 4 T细胞介导的免疫病理学严重程度中的作用。
英文摘要
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the leading cause of viral lower respiratory tract infection in infants and young children. In addition, RSV causes serious disease in elderly and immune compromised individuals. Immunization against RSV is associated with enhanced disease and pulmonary eosinophilia following natural infection that is thought to be caused by an exuberant memory CD4 Th2 response. As a consequence, there is currently no approved RSV vaccine and detailed studies directed towards prevention of vaccine-associated disease are a necessary first step in the development of a safe and effective vaccine. The BALB/c mouse model of RSV infection faithfully mimics the human respiratory disease including the development of extensive lung inflammation and injury, pulmonary eosinophilia, and enhanced disease in mice previously immunized with either formalin inactivated (FI)-RSV or a recombinant vaccinia virus (vv) that expresses the attachment (G) glycoprotein. Memory CD4 T cells secreting Th2 cytokines are necessary for this response because their depletion eliminates eosinophilia. Recent studies have demonstrated that RSV- specific CD8 T cells can inhibit Th2-mediated pulmonary eosinophilia in vvG-primed mice by as yet unknown mechanisms. By taking advantage of our ability to track RSV G-specific CD4 T cells, we will determine the mechanism of memory CD8 T cell inhibition of RSV G-induced pulmonary eosinophilia. Importantly, recent work has provided evidence that vvG and FI-RSV immunization may induce RSV vaccine-enhanced disease via unique mechanisms. Therefore, we will also ascertain if RSV-specific memory CD8 T cells can prevent FI-RSV vaccine-enhanced disease. The overall goal of this proposal is to define the mechanism(s) of how RSV-specific memory CD8 T cells inhibit CD4 T cell-mediated RSV vaccine-enhanced disease and immunopathology. We propose the following Specific Aims: 1) To determine the how memory CD8 T cells inhibit RSV-specific memory Th2 cells and RSV vaccine-enhanced pulmonary eosinophilia and, 2) To determine if memory CD8 T cells can prevent FI-RSV vaccine-enhanced disease and pulmonary injury. The underlying mechanisms of RSV vaccine-enhanced disease remain unclear. The studies in this proposal are designed to determine the role of RSV-specific memory CD8 T cells in decreasing the severity of CD4 T cell-mediated immunopathology in a model system with direct relevance to human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the complexities of inflammasome activation following RSV infection
-
批准号:10655297
-
项目类别:
-
资助金额:$66.54万
-
财政年份:2022
-
负责人:Steven M Varga
-
依托单位:
Deciphering the complexities of inflammasome activation following RSV infection
-
批准号:10388682
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2022
-
负责人:Steven M Varga
-
依托单位:
Deciphering the complexities of inflammasome activation following RSV infection
-
批准号:10807884
-
项目类别:
-
资助金额:$38.99万
-
财政年份:2022
-
负责人:Steven M Varga
-
依托单位:
RSV-induced inflammation in the brain
-
批准号:10252048
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2020
-
负责人:Steven M Varga
-
依托单位:
Balancing protection versus immunopathology by RSV-specific memory CD8 T cells
-
批准号:9977905
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2017
-
负责人:Steven M Varga
-
依托单位:
Role of TLR4 in Coronavirus Infection
-
批准号:7701085
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2009
-
负责人:Steven M Varga
-
依托单位:
Role of TLR4 in Coronavirus Infection
-
批准号:7860303
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2009
-
负责人:Steven M Varga
-
依托单位:
Immunopathology mediated by RSV-specific CD4 T cells
-
批准号:7568970
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2007
-
负责人:Steven M Varga
-
依托单位:
Immunopathology mediated by RSV-specific CD4 T cells
-
批准号:8013503
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2007
-
负责人:Steven M Varga
-
依托单位:
Immunopathology mediated by RSV-specific CD4 T cells
-
批准号:7758806
-
项目类别:
-
资助金额:$35.29万
-
财政年份:2007
-
负责人:Steven M Varga
-
依托单位:
Immunopathology mediated by RSV-specific CD4 T cells
-
批准号:7209559
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2007
-
负责人:Steven M Varga
-
依托单位:
Immunopathology mediated by RSV-specific CD4 T cells
-
批准号:7356021
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2007
-
负责人:Steven M Varga
-
依托单位:
GENETIC DETERMINANTS MEDIATING VIRUS INDUCED LUNG INJURY
-
批准号:6208861
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2000
-
负责人:Steven M Varga
-
依托单位:
GENETIC DETERMINANTS MEDIATING VIRUS INDUCED LUNG INJURY
-
批准号:6388787
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2000
-
负责人:Steven M Varga
-
依托单位:
海外基金